Loading clinical trials...
Loading clinical trials...
The GILUPI CellCollector® is the first in vivo CTC isolation product worldwide, which is CE approved. The purpose of this clinical trial is to evaluate the predictive value of CTC in neoadjuvant chemo...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
RenJi Hospital
Collaborators
NCT07347600 · Locally Advanced Breast Cancer, Metastatic Breast Cancer
NCT07085767 · Breast Cancer, Locally Advanced Breast Cancer, and more
NCT06878248 · Breast Cancer Metastatic, Locally Advanced Breast Cancer (LABC), and more
NCT06064812 · Metastatic Breast Cancer, Locally Advanced Breast Cancer, and more
NCT05508906 · Metastatic Breast Cancer, ER-positive Breast Cancer, and more
Renji Hospital, School of Medicine, Shanghai Jiao Tong University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions